HOLLY COLINDRES: Open Payments
NPI 1508175365 · OSPREY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,616 in 64 payments from 20 companies in 2025. Trend: 2023 $1,552 · 2024 $1,558 · 2025 $1,616
Food & beverage: $1,531Education: $85
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $250 |
| Janssen Biotech, Inc. | 7 | $202 |
| GENZYME CORPORATION | 6 | $188 |
| Galderma Laboratories, L.P. | 5 | $110 |
| Lilly USA, LLC | 4 | $105 |
| PFIZER INC. | 4 | $105 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $90 |
| Regeneron Healthcare Solutions, Inc. | 2 | $72 |
| ConvaTec Inc. | 3 | $63 |
Products named: DUPIXENT, ILUMYA, TREMFYA, SPEVIGO, EBGLYSS, INNOVAMATRIX AC, NEMLUVIO, CIBINQO.
Industry payments across FL — which companies pay providers there.
